New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has successfully finished patient enrolment for TRANSFORM II, one of the most ambitious and extensive randomised controlled trials (RCTs) ever carried out in the field of cardiovascular care, at a pivotal point for the future of interventional cardiology.
Sunday, June 15
Trending
- Rita Patel Shines: Gujarat-Born Athlete Named Player of the Year at Burnt Ash Hockey Club
- Sundeep Bhutoria Nominated to the Board of Victoria Memorial Hall by Ministry of Culture
- ECE Industries Ltd (Birla Group) Honored for ’80 Years of Excellence’ by ETNow.in Realty Awards 2025
- Gems & Jewellery Education Goes Global: Exploring ISGJ’s Game-Changing Rebrand
- BillWizz: Revolutionizing Online Bill Payments for Indians
- Vantage Announces Continued Global Commitment to Safe, Transparent Trading Access
- TRANSFORM II Trial Hits Enrollment Milestone: Redefining Coronary Care with Sirolimus-Coated Balloons
- Covero and FashionCart: Changing Online Shopping in India